Skip to main content
. 2014 Feb 28;10(1):51–60. doi: 10.17925/EE.2014.10.01.51

Figure 3: Summary Estimates from a Series of Meta-analyses of the Effect of Fructose on Cardiometabolic Risk Factors in Controlled Feeding Trials.

Figure 3:

Isocaloric trials (A) refer to trials in which fructose was exchanged for other sources of carbohydrate and in hypercaloric trials. Hypercaloric trials (B) refer to trials in which fructose-supplemented control diets with excess energy at high doses compared with the control diets alone (without the excess energy). *Evidence of significant interstudy heterogeneity by the Cochran Q statistic (p<0.05). CI = confidence interval; dBP = diastolic blood pressure; FBG = fasting blood glucose; FBI = fasting blood insulin; GBP = glycated blood proteins; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; MAP = mean arterial pressure; sBP = systolic blood pressure; SMD = standardised mean difference; TC = total cholesterol; TG = triglycerides. Adapted from Sievenpiper JL; Toronto 3D (Diet, Digestive Tract, and Disease) Knowledge Synthesis and Clinical Trials Unit.21